1.     Khalaily N, Hassan A, Khream Y, Naveh-Many T, Ben-Dov IZ. The roles of mTORC1 in parathyroid gland function in chronic kidney disease-induced secondary hyperparathyroidism: Evidence from male genetic mouse models and clinical data. FASEB J. 2024;38(22). doi:10.1096/fj.202401547RR
2.     Hassan A, Khalaily N, Kilav-Levin R, et al. Dicer-Mediated mTORC1 Signaling and Parathyroid Gland Integrity and Function. J Am Soc Nephrol. 2024;35(9):1183-1197. doi:10.1681/ASN.0000000000000394
3.     Hassan A, Khalaily N, Kilav-Levin R, et al. Molecular Mechanisms of Parathyroid Disorders in Chronic Kidney Disease. Metabolites. 2022;12(2). doi:10.3390/metabo12020111
4.     Egstrand S, Mace ML, Morevati M, et al. Hypomorphic expression of parathyroid Bmal1 disrupts the internal parathyroid circadian clock and increases parathyroid cell proliferation in response to uremia. Kidney Int. 2022;101(6):1232-1250. doi:10.1016/j.kint.2022.02.018
5.     Hassan A, Pollak YE, Kilav-Levin R, et al. Kidney Failure Alters Parathyroid Pin1 Phosphorylation and Parathyroid Hormone mRNA-Binding Proteins Leading to Secondary Hyperparathyroidism. J Am Soc Nephrol. 2022;33(9):1677-1693. doi:10.1681/ASN.2022020197
6.     Naveh-Many T, Volovelsky O. Parathyroid cell proliferation in secondary hyperparathyroidism of chronic kidney disease. Int J Mol Sci. 2020;21(12):1-17. doi:10.3390/ijms21124332
7.     Egstrand S, Nordholm A, Morevati M, et al. A molecular circadian clock operates in the parathyroid gland and is disturbed in chronic kidney disease associated bone and mineral disorder. Kidney Int. 2020;98(6):1461-1475. doi:10.1016/j.kint.2020.06.034
8.     Kilav-Levin R, Hassan A, Nechama M, et al. Post-transcriptional mechanisms regulating parathyroid hormone gene expression in secondary hyperparathyroidism. FEBS J. 2020;287(14):2903-2913. doi:10.1111/febs.15300
9.     Naveh-Many T, Silver J, Kronenberg HM. Parathyroid hormone molecular biology. In: Principles of Bone Biology. Elsevier; 2019:575-594. doi:10.1016/B978-0-12-814841-9.00024-5
10.     Durlacher-Betzer K, Hassan A, Levi R, Axelrod J, Silver J, Naveh-Many T. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease. Kidney Int. 2018;94(2):315-325. doi:10.1016/j.kint.2018.02.026
11.     Silver J, Naveh-Many T. Vitamin D and the Parathyroids. In: Vitamin D: Fourth Edition. Vol 1. Elsevier Inc.; 2018:461-475. doi:10.1016/B978-0-12-809965-0.00027-6
12.     Naveh-Many T, Silver J. Transcription factors that determine parathyroid development power PTH expression. Kidney Int. 2018;93(1):7-9. doi:10.1016/j.kint.2017.08.026
13.     Naveh-Many T, Silver J. The pas de trois of Vitamin D, FGF23, and PTH. J Am Soc Nephrol. 2017;28(2):393-395. doi:10.1681/ASN.2016090944
14.     Shilo V, Levi IM-Y, Abel R, et al. Let-7 and MicroRNA-148 regulate parathyroid hormone levels in secondary hyperparathyroidism. J Am Soc Nephrol. 2017;28(8):2353-2363. doi:10.1681/ASN.2016050585
15.     Hassan A, Durlacher K, Silver J, Naveh-Many T, Levi R. The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia. Am J Physiol - Ren Physiol. 2016;310(3):F217-F221. doi:10.1152/ajprenal.00332.2015
16.     Volovelsky O, Cohen G, Kenig A, et al. Phosphorylation of ribosomal protein S6 mediates mammalian target of rapamycin complex 1-induced parathyroid cell proliferation in secondary hyperparathyroidism. J Am Soc Nephrol. 2016;27(4):1091-1101. doi:10.1681/ASN.2015040339
17.     Shilo V, Silver J, Naveh-Many T. Micro-RNAs in the parathyroid: A new portal in understanding secondary hyperparathyroidism. Curr Opin Nephrol Hypertens. 2016;25(4):271-277. doi:10.1097/MNH.0000000000000227
18.     Naveh-Many T. Post-transcriptional regulation of parathyroid hormone gene expression in health and disease. In: Post-Transcriptional Mechanisms in Endocrine Regulation. Springer International Publishing; 2015:235-251. doi:10.1007/978-3-319-25124-0_11
19.     Shilo V, Ben-Dov IZ, Nechama M, Silver J, Naveh-Many T. Parathyroid-specific deletion of dicer-dependent microRNAs abrogates the response of the parathyroid to acute and chronic hypocalcemia and uremia. FASEB J. 2015;29(9):3964-3976. doi:10.1096/fj.15-274191
20.     Meir T, Durlacher K, Pan Z, et al. Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription. Kidney Int. 2014;86(6):1106-1115. doi:10.1038/ki.2014.215
21.     Silver J, Naveh-Many T. FGF-23 and secondary hyperparathyroidism in chronic kidney disease. Nat Rev Nephrol. 2013;9(11):641-649. doi:10.1038/nrneph.2013.147
22.     Tzour A, Sosial E, Meir T, et al. Multiple Pathways for High Voltage-Activated Ca2+ Influx in Anterior Pituitary Lactotrophs and Somatotrophs. J Neuroendocrinol. 2013;25(1):76-86. doi:10.1111/j.1365-2826.2012.02372.x
23.     Silver J, Naveh-Many T. FGF23 and the parathyroid. Adv Exp Med Biol. 2012;728:92-99. doi:10.1007/978-1-4614-0887-1_6
24.     Naveh-Many T, Nechama M. Molecular mechanisms of parathyroid hormone synthesis. In: Diseases of the Parathyroid Glands. Vol 9781441955500. Springer New York; 2012:1-12. doi:10.1007/978-1-4419-5550-0_1
25.     Silver J, Naveh-Many T. Vitamin D and the parathyroids. In: Vitamin D: Two-Volume Set. Vol 1-2. Elsevier; 2011:493-506. doi:10.1016/B978-0-12-381978-9.10027-7
26.     Silver J, Naveh-Many T. Vitamin D and the parathyroids. In: Vitamin D. Elsevier Inc.; 2011:493-506. doi:10.1016/B978-0-12-381978-9.10027-7
27.     Silver J, Naveh-Many T. Vitamin D and the Parathyroids. In: Nutrition and Health (United Kingdom). Vol Part F3885. Palgrave Macmillan; 2010:235-254. doi:10.1007/978-1-60327-303-9_10
28.     Lavi-Moshayoff V, Wasserman G, Meir T, Silver J, Naveh-Many T. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: A bone parathyroid feedback loop. Am J Physiol - Ren Physiol. 2010;299(4):F882-F889. doi:10.1152/ajprenal.00360.2010
29.     Silver J, Naveh-Many T. FGF23 and the parathyroid glands. Pediatr Nephrol. 2010;25(11):2241-2245. doi:10.1007/s00467-010-1565-3
30.     Naveh-Many T. Minireview: The play of proteins on the parathyroid hormone messenger ribonucleic acid regulates its expression. Endocrinology. 2010;151(4):1398-1402. doi:10.1210/en.2009-1160
31.     Galitzer H, Ben-Dov IZ, Silver J, Naveh-Many T. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int. 2010;77(3):211-218. doi:10.1038/ki.2009.464
32.     Reiss-Sklan E, Levitzki A, Naveh-Many T. The complex regulation of HIC (Human I-mfa domain containing protein) expression. PLoS One. 2009;4(7). doi:10.1371/journal.pone.0006152
33.     Meir T, Levi R, Lieben L, et al. Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology. Am J Physiol - Ren Physiol. 2009;297(5):F1192-F1198. doi:10.1152/ajprenal.00360.2009
34.     Silver J, Naveh-Many T. Phosphate and the parathyroid. Kidney Int. 2009;75(9):898-905. doi:10.1038/ki.2008.642
35.     Nechama M, Peng Y, Bell O, et al. KSRP-PMR1-exosome association determines parathyroid hormone mRNA levels and stability in transfected cells. BMC Cell Biol. 2009;10:70. doi:10.1186/1471-2121-10-70
36.     Lavi-Moshayoff V, Silver J, Naveh-Many T. Human PTH gene regulation in vivo using transgenic mice. Am J Physiol - Ren Physiol. 2009;297(3):F713-F719. doi:10.1152/ajprenal.00161.2009
37.     Galitzer H, Lavi-Moshayoff V, Nechama M, Meir T, Silver J, Naveh-Many T. The calcium-sensing receptor regulates parathyroid hormone gene expression in transfected HEK293 cells. BMC Biol. 2009;7. doi:10.1186/1741-7007-7-17
38.     Nechama M, Uchida T, Yosef-Levi IM, Silver J, Naveh-Many T. The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism. J Clin Invest. 2009;119(10):3102-3114. doi:10.1172/JCI39522
39.     Nechama M, Ben-Dov IZ, Silver J, Naveh-Many T. Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD. Am J Physiol - Ren Physiol. 2009;296(4):F795-F800. doi:10.1152/ajprenal.90625.2008
40.     Naveh-Many T, Silver J, Kronenberg HM. Parathyroid Hormone: Molecular Biology. In: Principles of Bone Biology: Volume 1-2, Third Edition. Elsevier; 2008:577-593. doi:10.1016/B978-0-12-373884-4.00047-1
41.     Galitzer H, Ben-Dov I, Lavi-Moshayoff V, Naveh-Many T, Silver J. Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion. Curr Opin Nephrol Hypertens. 2008;17(4):363-367. doi:10.1097/MNH.0b013e328303e172
42.     Nechama M, Ben-Dov IZ, Briata P, Gherzi R, Naveh-Many T. The mRNA decay promoting factor K-homology splicing regulator protein post-transcriptionally determines parathyroid hormone mRNA levels. FASEB J. 2008;22(10):3458-3468. doi:10.1096/fj.08-107250
43.     Naveh-Many T, Nechama M. Regulation of parathyroid hormone mRNA stability by calcium, phosphate and uremia. Curr Opin Nephrol Hypertens. 2007;16(4):305-310. doi:10.1097/MNH.0b013e3281c55ede
44.     Ben-Dov IZ, Pappo O, Sklair-Levy M, et al. Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats. Nephrol Dial Transplant. 2007;22(2):362-368. doi:10.1093/ndt/gfl623
45.     Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest. 2007;117(12):4003-4008. doi:10.1172/JCI32409
46.     Dinur M, Kilav R, Sela-Brown A, Jacquemin-Sablon H, Naveh-Many T. In vitro evidence that upstream of N-ras participates in the regulation of parathyroid hormone messenger ribonucleic acid stability. Mol Endocrinol. 2006;20(7):1652-1660. doi:10.1210/me.2005-0333
47.     Costa-Guda J, Lauter K, Naveh-Many T, Silver J, Arnold A. Mutational analysis of the PTH 3′-untranslated region in parathyroid disorders. Clin Endocrinol (Oxf). 2006;65(6):806-809. doi:10.1111/j.1365-2265.2006.02670.x
48.     Levi R, Ben-Dov IZ, Lavi-Moshayoff V, et al. Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: Correlation with posttranslational modification of the trans acting factor AUF1. J Am Soc Nephrol. 2006;17(1):107-112. doi:10.1681/ASN.2005070679
49.     Bell O, Gaberman E, Kilav R, et al. The protein phosphatase calcineurin determines basal parathyroid hormone gene expression. Mol Endocrinol. 2005;19(2):516-526. doi:10.1210/me.2004-0108
50.     Bell O, Silver J, Naveh-Many T. Identification and characterization of cis-acting elements in the human and bovine PTH mRNA 3′-untranslated region. J Bone Miner Res. 2005;20(5):858-866. doi:10.1359/JBMR.041227
51.     Silver J, Naveh-Many T. Vitamin D and the Parathyroids. In: Vitamin D. Vol 1. Elsevier Inc.; 2005:537-549. doi:10.1016/B978-012252687-9/50033-4
52.     Totary-Jain H, Naveh-Many T, Riahi Y, Kaiser N, Eckel J, Sasson S. Calreticulin destabilizes glucose transporter-1 mRNA in vascular endothelial and smooth muscle cells under high-glucose conditions. Circ Res. 2005;97(10):1001-1008. doi:10.1161/01.RES.0000189260.46084.e5
53.     Moz Y, Levi R, Lavi-Moshayoff V, et al. Calcineurin Aβ is central to the expression of the renal type II Na/Pi Co-transporter gene and to the regulation of renal phosphate transport. J Am Soc Nephrol. 2004;15(12):2972-2980. doi:10.1097/01.ASN.0000144207.44469.BE
54.     Silver J, Naveh-Many T. Vitamin D and the Parathyroids. In: Vitamin D, Second Edition. Elsevier; 2004:537-549. doi:10.1016/B978-012252687-9/50033-4
55.     Kilav R, Bell O, Le S-Y, Silver J, Naveh-Many T. The Parathyroid Hormone mRNA 3′-Untranslated Region AU-rich Element Is an Unstructured Functional Element. J Biol Chem. 2004;279(3):2109-2116. doi:10.1074/jbc.M305302200
56.     Moz Y, Silver J, Naveh-Many T. Characterization of cis-acting element in renal NaPi-2 cotransporter mRNA that determines mRNA stability. Am J Physiol - Ren Physiol. 2003;284(4 53-4):F663-F670. doi:10.1152/ajprenal.00332.2002
57.     Naveh-Many T, Bell O, Silver J, Kilav R. Cis and trans acting factors in the regulation of parathyroid hormone (PTH) mRNA stability by calcium and phosphate. FEBS Lett. 2002;529(1):60-64. doi:10.1016/S0014-5793(02)03259-3
58.     Silver J, Kilav R, Naveh-Many T. Mechanisms of secondary hyperparathyroidism. Am J Physiol - Ren Physiol. 2002;283(3 52-3):F367-F376. doi:10.1152/ajprenal.00061.2002
59.     Kilav R, Silver J, Naveh-Many T. A Conserved cis-Acting Element in the Parathyroid Hormone 3′-Untranslated Region is Sufficient for Regulation of RNA Stability by Calcium and Phosphate. J Biol Chem. 2001;276(12):8727-8733. doi:10.1074/jbc.M005471200
60.     Silver J, Kilav R, Sela-Brown A, Naveh-Many T. Molecular mechanisms of secondary hyperparathyroidism. Pediatr Nephrol. 2000;14(7):626-628. doi:10.1007/s004670000355
61.     Epstein E, Sela-Brown A, Ringel I, et al. Dynein light chain binding to a 3’-untranslated sequence mediates parathyroid hormone mRNA association with microtubules. J Clin Invest. 2000;105(4):505-512. doi:10.1172/JCI8557
62.     Sela-Brown A, Silver J, Brewer G, Naveh-Many T. Identification of AUF1 as a parathyroid hormone mRNA 3’-untranslated region-binding protein that determines parathyroid hormone mRNA stability. J Biol Chem. 2000;275(10):7424-7429. doi:10.1074/jbc.275.10.7424
63.     Sela-Brown A, Naveh-Many T, Silver J. Transcriptional and post-transcriptional regulation of PTH gene expression by vitamin D, calcium and phosphate. In: Mineral and Electrolyte Metabolism. Vol 25. S. Karger AG; 1999:342-344. doi:10.1159/000057471
64.     Naveh-Many T. Post-transcriptional regulation of the parathyroid hormone gene by calcium and phosphate. Curr Opin Nephrol Hypertens. 1999;8(4):415-419. doi:10.1097/00041552-199907000-00004
65.     Yalcindag C, Silver J, Naveh-Many T. Mechanism of increased parathyroid hormone mRNA in experimental uremia: Roles of protein RNA binding and RNA degradation. J Am Soc Nephrol. 1999;10(12):2562-2568. doi:10.1681/asn.v10122562
66.     Naveh-Many T, Sela-Brown A, Silver J. Protein-RNA interactions in the regulation of PTH gene expression by calcium and phosphate. Nephrol Dial Transplant. 1999;14(4):811-813. doi:10.1093/ndt/14.4.811
67.     Silver J, Yalcindag C, Sela-Brown A, Kilav R, Naveh-Many T. Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate. Kidney Int Suppl. 1999;56(73):S2-S7. doi:10.1046/j.1523-1755.1999.07310.x
68.     Moz Y, Silver J, Naveh-Many T. Protein-RNA interactions determine the stability of the renal NaPi-2 cotransporter mRNA and its translation in hypophosphatemic rats. J Biol Chem. 1999;274(36):25266-25272. doi:10.1074/jbc.274.36.25266
69.     Silver J, Moallem E, Kilav R, Sela A, Naveh-Many T. Regulation of the parathyroid hormone gene by calcium, phosphate and 1,25-dihydroxyvitamin D. In: Nephrology Dialysis Transplantation. Vol 13. ; 1998:40-44. doi:10.1093/ndt/13.suppl_1.40
70.     Moallem E, Kilav R, Silver J, Naveh-Many T. RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J Biol Chem. 1998;273(9):5253-5259. doi:10.1074/jbc.273.9.5253
71.     Sela-Brown A, Russell J, Koszewski NJ, Michalak M, Naveh-Many T, Silver J. Calreticulin inhibits vitamin D’s action on the PTH gene in vitro and may prevent vitamin D’s effect in vivo in hypocalcemic rats. Mol Endocrinol. 1998;12(8):1193-1200. doi:10.1210/mend.12.8.0148
72.     Marks KH, Kilav R, Berman E, Naveh-Many T, Silver J. Parathyroid hormone gene expression in Hyp mice fed a low-phosphate diet. Nephrol Dial Transplant. 1997;12(8):1581-1585. doi:10.1093/ndt/12.8.1581
73.     Silver J, Sela SB, Naveh-Many T. Regulation of parathyroid cell proliferation. Curr Opin Nephrol Hypertens. 1997;6(4):321-326. doi:10.1097/00041552-199707000-00004
74.     Cohen Y, Rahamimov R, Naveh-Many T, Silver J, Rahamimoff R. Where is the “inverting factor” in hormone secretion from parathyroid cells? Am J Physiol - Endocrinol Metab. 1997;273(3 36-3):E630-E637. doi:10.1152/ajpendo.1997.273.3.e630
75.     Cohen Y, Rahamimov R, Naveh-Many T, Silver J, Rahamimoff R. Where is the “inverting factor” in hormone secretion from parathyroid cells? Am J Physiol. 1997;273(3 PART 1):E584-E592. https://www.scopus.com/inward/record.uri?eid=2-s2.0-33745392648&partnerID=40&md5=2702433843cc186856ca39d658cd73cb
76.     Silver J, Moallem E, Kilav R, Epstein E, Sela A, Naveh-Many T. New insights into the regulation of parathayroid hormone synthesis and secretion in chronic renal failure. In: Nephrology Dialysis Transplantation. Vol 11. Oxford University Press; 1996:2-5. doi:10.1093/ndt/11.supp3.2
77.     Marks KH, Kilav R, Naveh-Many T, Silver J. Calcium, phosphate, vitamin D, and the parathyroid. In: Pediatric Nephrology. Vol 10. Springer Verlag; 1996:364-367. doi:10.1007/BF00866787
78.     Epstein E, Silver J, Almogi G, Livni N, Naveh-Many T. Parathyroid hormone mRNA levels are increased by progestins and vary during rat estrous cycle. Am J Physiol - Endocrinol Metab. 1996;270(1 33-1):E158-E163. doi:10.1152/ajpendo.1996.270.1.e158
79.     Lytton J, Lee S-L, Lee W-S, et al. The kidney sodium-calcium exchanger. In: Annals of the New York Academy of Sciences. Vol 779. Blackwell Publishing Inc.; 1996:58-72. doi:10.1111/j.1749-6632.1996.tb44770.x
80.     Silver J, Epstein E, Naveh-Many T. Oestrogen deficiency - Does it have a role in the genesis of skeletal problems in dialysed women? Nephrol Dial Transplant. 1996;11(4):565-566. doi:10.1093/oxfordjournals.ndt.a027340
81.     Naveh-Many T, Epstein E, Silver J. Oestrogens and calcium regulatory hormones: Potential implications for bone. Curr Opin Nephrol Hypertens. 1995;4(4):319-323. doi:10.1097/00041552-199507000-00006
82.     Moallem E, Silver J, Naveh‐Many T. Regulation of parathyroid hormone messenger RNA levels by protein kinase A and C in bovine parathyroid cells. J Bone Miner Res. 1995;10(3):447-452. doi:10.1002/jbmr.5650100316
83.     Naveh-Many T, Rahamimov R, Livni N, Silver J. Parathyroid cell proliferation in normal and chronic renal failure rats: The effects of calcium, phosphate, and vitamin D. J Clin Invest. 1995;96(4):1786-1793. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028858407&partnerID=40&md5=8f4d1dd1be71c0fafa4406c0e962ff15
84.     Kilav R, Silver J, Naveh-Many T. Parathyroid hormone gene expression in hypophosphatemic rats. J Clin Invest. 1995;96(1):327-333. doi:10.1172/jci118038
85.     Kilav R, Silver J, Biber J, Murer H, Naveh-Many T. Coordinate regulation of rat renal parathyroid hormone receptor mRNA and Na-Pi cotransporter mRNA and protein. Am J Physiol - Ren Fluid Electrolyte Physiol. 1995;268(6 37-6):F1017-F1022. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028814702&partnerID=40&md5=e8aef61f23891b3fa7508e00f039a210
86.     Silver J, Naveh-Many T. Regulation of parathyroid hormone synthesis and secretion. Semin Nephrol. 1994;14(2):175-194. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028345282&partnerID=40&md5=2c4591f05dd4c7692fb31e595b614637
87.     Silver J, Moallem E, Epstein E, Kilav R, Naveh-Many T. New aspects in the control of parathyroid hormone secretion. Curr Opin Nephrol Hypertens. 1994;3(4):379-385. doi:10.1097/00041552-199407000-00003
88.     Grauer A, Klein P, Naveh-Many T, Silver J, Ziegler R, Raue F. Diminished calcitonin secretion after ovariectomy without apparent reduction in calcitonin content in the rat. Horm Metab Res. 1993;25(7):389-390. doi:10.1055/s-2007-1002126
89.     Silver J, Naveh-Many T. Calcitonin gene regulation in vivo. In: Hormone and Metabolic Research. Vol 25. ; 1993:470-472. doi:10.1055/s-2007-1002151
90.     Naveh-Many T, Silver J. Effects of calcitriol, 22-oxacalcitriol, and calcipotriol on serum calcium and parathyroid hormone gene expression. Endocrinology. 1993;133(6):2724-2728. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027131712&partnerID=40&md5=ea375f9b403dea1064e6c19088c251d4
91.     Naveh-Many T, Almogi G, Livni N, Silver J. Estrogen receptors and biologic response in rat parathyroid tissue and C cells. J Clin Invest. 1992;90(6):2434-2438. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027093580&partnerID=40&md5=e43bba8825a50762dbc86ef52803ba4f
92.     Naveh‐Many T, Raue F, Grauer A, Silver J. Regulation of calcitonin gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. J Bone Miner Res. 1992;7(10):1233-1237. doi:10.1002/jbmr.5650071016
93.     Silver J, Marks R, Naveh-Many T. Regulation of parathyroid hormone and calcitonin gene expression by 1,25-dihydroxy vitamin D3 and calcium. In: Calcium Regulation and Bone Metabolism. Basic and Clinical Aspects: Proceedings of the 10th International Conference on Calcium Regulating Hormones and Bone Metabolism. ICS886. Elsevier Science Publishers B.V.; 1990:140-145. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025049362&partnerID=40&md5=82c838c53c080d21eea4d1dd0c93faff
94.     Naveh-Many T, Marx R, Keshet E, Pike JW, Silver J. Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo. J Clin Invest. 1990;86(6):1968-1975. doi:10.1172/JCI114931
95.     Shvil Y, Naveh-Many T, Barach P, Silver J. Regulation of parathyroid cell gene expression in experimental uremia. J Am Soc Nephrol. 1990;1(1):99-104. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025462966&partnerID=40&md5=a62850ffba4bc1469649a11a9a10f0db
96.     Naveh-Many T, Silver J. Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. J Clin Invest. 1990;86(4):1313-1319. https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025053995&partnerID=40&md5=ac01ed8f21b34e815abfdf91fe4b68d8
97.     Naveh-Many T, Silver J. Regulation of calcitonin gene transcription by vitamin D metabolites in vivo in the rat. J Clin Invest. 1988;81(1):270-273. doi:10.1172/JCI113305
98.     Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest. 1986;78(5):1296-1301. doi:10.1172/JCI112714
99.     Razin A, Webb C, Szyf M, et al. Variations in DNA methylation during mouse cell differentiation in vivo and in vitro. Proc Natl Acad Sci U S A. 1984;81(8 I):2275-2279. doi:10.1073/pnas.81.8.2275
100.     Cedar H, Stein R, Gruenbaum Y, Naveh-Many T, Sciaky-Gallili N, Razin A. Effect of DNA methylation on gene expression. Cold Spring Harb Symp Quant Biol. 1982;47(2):605-609. doi:10.1101/sqb.1983.047.01.071
101.     Naveh-Many T, Cedar H. Topographical distribution of 5-methylcytosine in animal and plant DNA. Mol Cell Biol. 1982;2(7):758-762. doi:10.1128/MCB.2.7.758
102.     Gruenbaum Y, Naveh-many T, Cedar H, Razin A. Sequence specificity of methylation in higher plant DNA. Nature. 1981;292(5826):860-862. doi:10.1038/292860a0
103.     Naveh-Many T, Cedar H. Active gene sequences are undermethylated. Proc Natl Acad Sci U S A. 1981;78(7 I):4246-4250. doi:10.1073/pnas.78.7.4246